F-Star collaboration

By CT Team | May 31, 2018

As announced today (May 31), Confluence Tax is delighted to have assisted F-star on the acquisition of the asset-centric vehicle F-Star Gamma by Denali Therapeutics, leveraging F-star’s Modular Antibody Technology™ beyond immuno-oncology. Read the full press release here. 

Read More

Tax structuring advice for F-star collaboration

By CT Team | June 16, 2017
F-star-hi-Res-Logo

CONFLUENCE Tax is delighted to have provided tax structuring advice to F-star Delta, the fourth asset-centric vehicle in the F-star family, in its recent immuno-oncology collaboration. This deal underscores the attractiveness of F-star’s asset-centric business model, which provides a flexible deal-making framework while at the same time maximises the value of F-star’s bispecific programmes and…

Read More